G-CSF: a pathogenic effector in chronic obstructive pulmonary disease and its comorbidities

G-CSF：慢性阻塞性肺疾病及其合并症的致病效应物

• 批准号: nhmrc : GNT1141208
• 负责人: A/Pr Margaret Hibbs
• 金额: $ 124.16万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/g-csf-pathogenic-disease-comorbidities/1348357
• 关键词: CSF; pathogenic; effector; chronic; obstructive

Chronic Obstructive Pulmonary Disease (COPD) is an incurable lung disease that is a huge global health burden, and new therapies are urgently needed. We have recently discovered a possible cause of COPD. This single factor also appears to drive other associated medical problems that are the biggest contributors to patient deterioration. Using advanced genetics, biochemistry and molecular methods we are searching for ways to turn our discovery into effective treatments for this fatal disease.

慢性阻塞性肺疾病（COPD）是一种无法治愈的肺部疾病，是一个巨大的全球健康负担，迫切需要新的治疗方法。我们最近发现了COPD的可能原因。这一单一因素似乎也会导致其他相关的医疗问题，这些问题是导致患者病情恶化的最大因素。利用先进的遗传学，生物化学和分子方法，我们正在寻找将我们的发现转化为这种致命疾病的有效治疗方法的方法。